Privium Fund Management B.V.
- SEC CIK
- 0001795097
- Latest filing
- Aug 7, 2026
FDMT holding history
4D Molecular Therapeutics, Inc. in every 13F filed by Privium Fund Management B.V., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 90,110
- Value
- $1.20M
- % of portfolio
- 0.2%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 90,110 | $1.20M | 0.2% | −80,146−47.1% | Reduced | Holders |
| Q1 2026 | 170,256 | $1.59M | 0.3% | −39,744−18.9% | Reduced | Holders |
| Q4 2025 | 210,000 | $1.57M | 0.3% | +12,542+6.4% | Added | Holders |
| Q3 2025 | 197,458 | $1.72M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 197,458 | $819.5K | 0.2% | +66,458+50.7% | Added | Holders |
| Q1 2025 | 131,000 | $423.1K | 0.1% | +10,000+8.3% | Added | Holders |
| Q4 2024 | 121,000 | $674.0K | 0.2% | +22,500+22.8% | Added | Holders |
| Q3 2024 | 98,500 | $1.06M | 0.3% | +58,500+146.3% | Added | Holders |
| Q2 2024 | 40,000 | $823.2K | 0.2% | +9,000+29.0% | Added | Holders |
| Q1 2024 | 31,000 | $987.7K | 0.3% | −2,680−8.0% | Reduced | Holders |
| Q4 2023 | 33,680 | $715.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 33,680 | $428.7K | 0.1% | +33,680 | New | Holders |